CG
COEPW

Cutler Group’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Cutler Group’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$0 Sell
7,500
-2,500
-25% -$103 ﹤0.01% 2460
2023
Q4 		$0 Hold
10,000
– – ﹤0.01% 3697
2023
Q3 		$0 Hold
10,000
– – ﹤0.01% 3853
2023
Q2 		$0 Hold
10,000
– – ﹤0.01% 3649
2023
Q1 		$1K Hold
10,000
– – ﹤0.01% 3365
2022
Q4 		$1K Buy
+10,000
New +$668 ﹤0.01% 3951

Other funds holding COEPW

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Cutler Group's COEPW Position: Q1 2024 in Review

Cutler Group reduced its Coeptis Therapeutics Warrants (COEPW) stake by 25% in Q1 2024, selling an estimated $103 and leaving 7,500 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Cutler Group first reported a position in COEPW in Q4 2022 and has held it in 6 quarters since. The position peaked at $1K in Q1 2023. 20 funds tracked by Wall St. Rank hold COEPW as of Q1 2024.

  • Cutler Group held 7,500 shares of Coeptis Therapeutics Warrants worth $0 as of Q1 2024.
  • Cutler Group sold 2,500 Coeptis Therapeutics Warrants shares in Q1 2024, an estimated $103.
  • Coeptis Therapeutics Warrants made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #2460 holding.
  • Cutler Group first reported a position in Coeptis Therapeutics Warrants in Q4 2022 and has held it in 6 quarters since.
  • Cutler Group's Coeptis Therapeutics Warrants position peaked at $1K in Q1 2023.
  • 20 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.